Reports of miRs acting as oncogenes in prostate cancer have included miR-650, which suppresses CSR1 and consequently increasing metastasis [29], and miR-106a, which targets PTEN to promote proliferation, migration and invasion [30]. Here, PTEN is linked to prostate carcinoma.